- $108.28m
- $146.04m
- $151.88m
- 71
- 67
- 54
- 69
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 117 | 111 | 120 | 150 | 152 |
Cost of Revenue | |||||
Gross Profit | 104 | 96.9 | 105 | 132 | 132 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 107 | 146 | 122 | 146 | 146 |
Operating Profit | 10.1 | -34.4 | -1.75 | 3.26 | 5.99 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 9.43 | -35.2 | -1.03 | 3.6 | 3.62 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6.63 | -32.4 | -0.402 | 4.18 | 3.49 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 12.6 | -30 | -29.7 | 4.18 | 3.49 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 12.6 | -30 | -29.7 | 4.18 | 3.49 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.155 | -0.119 | 0.046 | 0.128 | 0.163 |